Sanara Medtech Stock Forecast - Accumulation Distribution
| SMTI Stock | USD 35.94 0.42 1.16% |
Sanara Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Sanara Medtech's historical fundamentals, such as revenue growth or operating cash flow patterns.
Sanara |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 2637.66 | 224.76 |
| Check Sanara Medtech Volatility | Backtest Sanara Medtech | Trend Details |
Sanara Medtech Trading Date Momentum
| On October 09 2024 Sanara Medtech was traded for 32.08 at the closing time. The top price for the day was 32.51 and the lowest listed price was 31.24 . The trading volume for the day was 21.6 K. The trading history from October 9, 2024 was a factor to the next trading day price growth. The trading price change against the next closing price was 3.62% . The trading price change against the current closing price is 4.10% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Sanara Medtech to competition |
Other Forecasting Options for Sanara Medtech
For every potential investor in Sanara, whether a beginner or expert, Sanara Medtech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sanara Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sanara. Basic forecasting techniques help filter out the noise by identifying Sanara Medtech's price trends.Sanara Medtech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sanara Medtech stock to make a market-neutral strategy. Peer analysis of Sanara Medtech could also be used in its relative valuation, which is a method of valuing Sanara Medtech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Sanara Medtech Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Sanara Medtech's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Sanara Medtech's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sanara Medtech Market Strength Events
Market strength indicators help investors to evaluate how Sanara Medtech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sanara Medtech shares will generate the highest return on investment. By undertsting and applying Sanara Medtech stock market strength indicators, traders can identify Sanara Medtech entry and exit signals to maximize returns.
| Accumulation Distribution | 1922.37 | |||
| Daily Balance Of Power | (0.20) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 36.03 | |||
| Day Typical Price | 36.0 | |||
| Market Facilitation Index | 1.0E-4 | |||
| Price Action Indicator | (0.30) | |||
| Period Momentum Indicator | (0.42) | |||
| Relative Strength Index | 61.46 |
Sanara Medtech Risk Indicators
The analysis of Sanara Medtech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sanara Medtech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sanara stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.42 | |||
| Semi Deviation | 2.82 | |||
| Standard Deviation | 3.13 | |||
| Variance | 9.78 | |||
| Downside Variance | 8.83 | |||
| Semi Variance | 7.95 | |||
| Expected Short fall | (2.49) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Sanara Medtech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanara Medtech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanara Medtech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanara Medtech Stock:Check out Historical Fundamental Analysis of Sanara Medtech to cross-verify your projections. For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanara Medtech. If investors know Sanara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanara Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.99) | Revenue Per Share 9.241 | Quarterly Revenue Growth 0.352 | Return On Assets (0.05) | Return On Equity (0.20) |
The market value of Sanara Medtech is measured differently than its book value, which is the value of Sanara that is recorded on the company's balance sheet. Investors also form their own opinion of Sanara Medtech's value that differs from its market value or its book value, called intrinsic value, which is Sanara Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanara Medtech's market value can be influenced by many factors that don't directly affect Sanara Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanara Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanara Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanara Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.